<DOC>
	<DOCNO>NCT00385905</DOCNO>
	<brief_summary>The Trial aim evaluate long-term efficiency Excel stent inhibition restenosis well safety cessation 6-month anti-platelet drug treatment .</brief_summary>
	<brief_title>Excel Drug-Eluting Stent Pilot Clinical Registry</brief_title>
	<detailed_description>30-day , 6-month , 12-month clinical follow-up 6 9-month IVUS SCA follow-up measure long-term efficiency Excel stent inhibition restenosis well safety cessation 6-month anti-platelet drug treatment .</detailed_description>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<criteria>Patients fulfill criterion implant Excel stent . Each patient enrol allow implant Excel stent . Each patient allow implanted 6 Excel stents.Also , 3 overlap stent allow implanted vessel ( 35mm overlap need ; length stent totally allow 80mm ; fully postdilated essential overlapping ) . Patients acknowlegement trial essential . AMI withine 1 week . Patients suitable Excel stenting . ( For example , nontolerant antiplatelet drug cardiac/noncardiac surgery undergo recently . ) Patients multiple branch lesion apply single Excel stenting . Patients refuse sign Trial Acknowledgement . Patients intrastent restenosis .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
</DOC>